Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...

According to InvestingPro data, Amedisys maintains a "Good" overall financial health score, with trailing twelve-month revenue reaching $2.35 billion. The company currently trades near its 52-week ...

Addressing social determinants of health (SDoH) is becoming increasingly important due to new regulations from the Centers ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...

Among the blue-chip-laden Dow Jones Industrial Average (DJINDICES: ^DJI), the two worst-performing stocks in the month of ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing issued late ...

(AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter ... surveyed by Zacks Investment Research was for earnings of $1.05 per share. The home health care and hospice services provider ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...

Amedisys, Inc. (the “Company”) is a leading healthcare services company, delivering personalized home health, hospice and high acuity care services in the home. Amedisys is focused on ...